The general manager took part in the
The "2012 china international antibody drug summit" was held from June 6-7 in Shanghai. The general manager Quangao Hua was invited to take part in it.
The monoclonal antibody technique has attracted more and more attention in the world in recent years. Antibody drugs keep an annual growth of fifty percent in the Chinese market, and the research of antibody drug has been listed in the national key research projects. China's huge potential market needs to be developed.
The conference was focused on the development prospects of antibody drugs, policy priorities, the key technology progress of antibody drug and so on. Through face-to-face exchange with experts at home and abroad, we better understood the technical bottleneck of antibody drug development. We have reason to believe that with the development of science and technology, antibody drugs will become a hot spot in future international biological medicine field.
As a high-tech enterprise specialized in producing scientific reagent, CUSABIO has been keeping an eye on new trends of research and production at home and abroad. The general manager had a deep talk with the counterparts and pharmaceutical manufacturers' representatives, and finally reached a consensus, which would provide a wide space for future development of CUSABIO.
Cite this article
CUSABIO team. The general manager took part in the . https://www.cusabio.com/c-14465.html
